New Enterprise Associates 15, L.P. Arcellx, Inc. (ACLX) insider trading activity

New Enterprise Associates 15, L.P. is > 10% Shareholder of Arcellx, Inc.. Currently has a direct ownership of 4.75 Million shares of ACLX, which is worth approximately $358 Million. The most recent transaction as insider was on Dec 20, 2022, when has been sold 2,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.75M

0% 3M change

0% 12M change

Total Value Held $358 Million

New Enterprise Associates 15, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 20 2022	SELL Other acquisition or disposition	-	2,000,000 Reduced 29.65%	4,745,262 Common Stock
Jun 21 2022	BUY Open market or private purchase	$5,000,000 $16.0 p/Share	312,500 Added 4.43%	6,745,262 Common Stock
Feb 08 2022	BUY Conversion of derivative security	-	4,849,429 Added 50.0%	4,849,429 Common Stock
Feb 08 2022	BUY Open market or private purchase	$23,749,995 $15.0 p/Share	1,583,333 Added 19.75%	6,432,762 Common Stock

Also insider at

EAR

Eargo, Inc. Healthcare

> 10% Shareholder

RPHM

Reneo Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

Desktop Metal, Inc. Technology

> 10% Shareholder

BHG

Bright Health Group Inc. Healthcare

HOOD

Robinhood Markets, Inc. Technology

Director

IONQ

IonQ, Inc. Technology

> 10% Shareholder

AVEO

AVEO PHARMACEUTICALS, INC. Healthcare

> 10% Shareholder

BGRY

Berkshire Grey, Inc. Industrials

> 10% Shareholder

NEA